FDA NDC Directory · JSON-LD · Markdown

Teriparatide

NDC 68001-693 · HUMAN PRESCRIPTION DRUG · INJECTION

Labeler / ManufacturerBluePoint Laboratories
Marketing categoryAbbreviated NDA (generic) · App ANDA213641
Dosage form / routeINJECTION · SUBCUTANEOUS
Active ingredientsTERIPARATIDE (250 ug/mL)
Marketing started20260319
Package count1

External sources

Source: openFDA. Public-domain (CC0).